• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.视网膜疾病患者效用评估中时间权衡法和标准博弈法的有效性
Br J Ophthalmol. 2002 May;86(5):493-6. doi: 10.1136/bjo.86.5.493.
2
Vision and quality-of-life.视力与生活质量。
Trans Am Ophthalmol Soc. 1999;97:473-511.
3
Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.新加坡人群年龄相关性黄斑变性 EuroQOL-5D、时间权衡和标准博弈的有效性。
Eye (Lond). 2012 Mar;26(3):379-88. doi: 10.1038/eye.2011.218. Epub 2012 Jan 6.
4
A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes.与视力的效用分析相关性:较好眼和较差眼的方法及视力情况
Int Ophthalmol. 2001;24(3):123-7. doi: 10.1023/a:1021171000838.
5
Health-related quality of life in patients with uveitis.葡萄膜炎患者的健康相关生活质量。
Br J Ophthalmol. 2019 Sep;103(9):1284-1288. doi: 10.1136/bjophthalmol-2018-312882. Epub 2018 Oct 25.
6
Utility values in the visually impaired: comparing time-trade off and VisQoL.视障人士的效用值:时间权衡法与视觉生活质量量表的比较
Optom Vis Sci. 2013 Aug;90(8):843-54. doi: 10.1097/OPX.0b013e318291063a.
7
Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine.患者对临床常规中新血管性年龄相关性黄斑变性治疗的偏好。
Br J Ophthalmol. 2012 Jul;96(7):997-1002. doi: 10.1136/bjophthalmol-2011-301201. Epub 2012 Apr 25.
8
A rating scale is a proper method to evaluate changes in quality of life due to dry eye symptoms.评分量表是评估干眼症状导致的生活质量变化的合适方法。
Int Ophthalmol. 2019 Mar;39(3):563-569. doi: 10.1007/s10792-018-0847-9. Epub 2018 Feb 7.
9
The impact of age-related macular degeneration on health status utility values.年龄相关性黄斑变性对健康状况效用值的影响。
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4016-23. doi: 10.1167/iovs.05-0072.
10
Is utility-based quality of life in adults affected by glaucoma?成年人的基于效用的生活质量是否受到青光眼的影响?
Invest Ophthalmol Vis Sci. 2014 Mar 6;55(3):1361-9. doi: 10.1167/iovs.13-13729.

引用本文的文献

1
Health Preferences in Transition: Differences from Pandemic to Post-Pandemic in Valuation of COVID-19 and RSV Illness in Children and Adults.转型期的健康偏好:儿童和成人对新冠病毒和呼吸道合胞病毒疾病评估从疫情期间到疫情后时期的差异
Children (Basel). 2025 Jan 31;12(2):181. doi: 10.3390/children12020181.
2
Preferences and choice in clinical decision-making with the help of time trade-off and standard gamble techniques among periodontally compromised patients - A cross-sectional study.牙周病患者借助时间权衡法和标准博弈技术在临床决策中的偏好与选择——一项横断面研究
J Indian Soc Periodontol. 2024 May-Jun;28(3):319-324. doi: 10.4103/jisp.jisp_471_23. Epub 2024 Dec 2.
3
Measuring Quality of Life in Diabetic Retinal Disease: A Narrative Review of Available Patient-Reported Outcome Measures.糖尿病视网膜病变患者生活质量的测量:对现有患者报告结局指标的叙述性综述
Ophthalmol Sci. 2023 Aug 9;4(2):100378. doi: 10.1016/j.xops.2023.100378. eCollection 2024 Mar-Apr.
4
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.预防优于治疗:叶黄素治疗新生血管性年龄相关性黄斑变性的5年随访、成本效益和成本效益分析
Ophthalmol Ther. 2023 Oct;12(5):2583-2608. doi: 10.1007/s40123-023-00742-9. Epub 2023 Jul 10.
5
Quantifying health utilities of young adult orthodontic patients using the time trade-off method: a cross-sectional study.采用时间权衡法量化青少年正畸患者的健康效用:一项横断面研究。
Dental Press J Orthod. 2023 Jun 5;28(2):e2321238. doi: 10.1590/2177-6709.28.2.e2321238.oar. eCollection 2023.
6
Determining health-related quality of life and health state utility values of recurrent urinary tract infections in women.确定女性复发性尿路感染的健康相关生活质量和健康状态效用值。
Int Urogynecol J. 2023 Aug;34(8):1831-1835. doi: 10.1007/s00192-023-05468-7. Epub 2023 Feb 8.
7
Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.减少眼科成本效用分析中潜在偏倚的机会。
JAMA Ophthalmol. 2021 Apr 1;139(4):389-397. doi: 10.1001/jamaophthalmol.2020.6591.
8
Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria.尼日利亚镰状细胞病患者健康相关生活质量的偏好测量及其决定因素。
PLoS One. 2019 Nov 18;14(11):e0223043. doi: 10.1371/journal.pone.0223043. eCollection 2019.
9
Ready-made and custom-made eyeglasses in India: a cost-effectiveness analysis of a randomised controlled trial.印度的成品眼镜和定制眼镜:一项随机对照试验的成本效益分析
BMJ Open Ophthalmol. 2018 Feb 9;3(1):e000123. doi: 10.1136/bmjophth-2017-000123. eCollection 2018.
10
The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.雷珠单抗治疗新生血管性黄斑变性的比较疗效和成本效益再探讨。
Int J Retina Vitreous. 2017 Feb 13;3:5. doi: 10.1186/s40942-016-0058-3. eCollection 2017.

本文引用的文献

1
The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis.格栅激光光凝术治疗糖尿病性黄斑水肿的成本效益:基于患者的成本效用分析结果
Curr Opin Ophthalmol. 2000 Jun;11(3):175-9. doi: 10.1097/00055735-200006000-00004.
2
Incremental cost-effectiveness of laser therapy for choroidal neovascularization associated with histoplasmosis.激光治疗组织胞浆菌病相关性脉络膜新生血管的增量成本效果分析
Retina. 2000;20(4):331-7. doi: 10.1097/00006982-200007000-00002.
3
Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization.激光光凝治疗黄斑下脉络膜新生血管的增量成本效果
Ophthalmology. 2000 Jul;107(7):1374-80. doi: 10.1016/s0161-6420(00)00169-x.
4
Utility values and age-related macular degeneration.效用值与年龄相关性黄斑变性
Arch Ophthalmol. 2000 Jan;118(1):47-51. doi: 10.1001/archopht.118.1.47.
5
Validity of the visual function index (VF-14) in patients with retinal disease.视网膜疾病患者视觉功能指数(VF-14)的有效性
Arch Ophthalmol. 1999 Dec;117(12):1611-6. doi: 10.1001/archopht.117.12.1611.
6
Cost-effectiveness of treatment for threshold retinopathy of prematurity.阈值早产儿视网膜病变治疗的成本效益
Pediatrics. 1999 Oct;104(4):e47. doi: 10.1542/peds.104.4.e47.
7
Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.确定51项美国国立眼科研究所视觉功能问卷的内容领域:来自与视力受损者焦点小组的结果。
Arch Ophthalmol. 1998 Feb;116(2):227-33. doi: 10.1001/archopht.116.2.227.
8
Measuring health-related quality of life.测量与健康相关的生活质量。
Ann Intern Med. 1993 Apr 15;118(8):622-9. doi: 10.7326/0003-4819-118-8-199304150-00009.
9
The VF-14. An index of functional impairment in patients with cataract.VF - 14。白内障患者功能损害指数。
Arch Ophthalmol. 1994 May;112(5):630-8. doi: 10.1001/archopht.1994.01090170074026.
10
A taxonomy of health status instruments.健康状况评估工具的分类法。
J Rheumatol. 1995 Jun;22(6):1188-90.

视网膜疾病患者效用评估中时间权衡法和标准博弈法的有效性

Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.

作者信息

Sharma S, Brown G C, Brown M M, Hollands H, Robins R, Shah G K

机构信息

Cost-Effective Ocular Health Policy Unit, Department of Ophthalmology, Queen's University, Hotel Dieu Hospital, Kingston, ON, Canada.

出版信息

Br J Ophthalmol. 2002 May;86(5):493-6. doi: 10.1136/bjo.86.5.493.

DOI:10.1136/bjo.86.5.493
PMID:11973240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1771136/
Abstract

AIM

To assess the validity of the time trade-off (TTO) and standard reference gamble (SRG) techniques of utility assessment in patients with retinal disease. A cross section of eligible patients was studied and validity was determined through their relation with two logical constructs, visual acuity and scores from the Visual Function 14 (VF-14) index.

METHODS

The study consisted of eligible patients presenting to a tertiary retinal facility who completed an interview. All patients had best corrected vision of 20/40 or worse in at least one eye. TTO and SRG utilities, as well as a VF-14 questionnaire, were administered through a standardised interview. Demographic and clinical (including Snellen visual acuity) information was also collected.

RESULTS

323 patients met these study criteria. Significant predictors of TTO utilities in the multivariate analysis were vision in the better seeing eye (p<0.01) and VF-14 scores (p<0.01). Significant predictors of standard gamble utilities were also vision in the better seeing eye (p<0.01) and VF-14 scores (p<0.05).

CONCLUSION

Both the standard gamble and TTO methods demonstrate strong validity when evaluated against visual acuity in the better seeing eye and the VF-14 score.

摘要

目的

评估时间权衡法(TTO)和标准参考博弈法(SRG)在视网膜疾病患者效用评估中的有效性。对符合条件的患者进行横断面研究,并通过其与两个逻辑结构的关系来确定有效性,这两个逻辑结构为视力和视觉功能14(VF - 14)指数得分。

方法

该研究包括到三级视网膜疾病治疗机构就诊并完成访谈的符合条件的患者。所有患者至少一只眼睛的最佳矫正视力为20/40或更差。通过标准化访谈来实施TTO和SRG效用评估,以及VF - 14问卷。还收集了人口统计学和临床(包括斯内伦视力)信息。

结果

323名患者符合这些研究标准。多变量分析中,TTO效用的显著预测因素为视力较好眼睛的视力(p<0.01)和VF - 14得分(p<0.01)。标准博弈效用的显著预测因素也是视力较好眼睛的视力(p<0.01)和VF - 14得分(p<0.05)。

结论

当对照视力较好眼睛的视力和VF - 14得分进行评估时,标准博弈法和TTO法均显示出很强的有效性。